Literature DB >> 2526768

The insulin secretory granule.

J C Hutton1.   

Abstract

The insulin secretory granule of the pancreatic B cell is a complex intracellular organelle comprised of a many proteins with different catalytic activities and messenger functions. With the advent of tumour models of the B cells and the application of immunological and molecular cloning techniques considerable progress has been made in recent years towards the elucidation of the structure and function of these granule proteins. A number of examples are selected here for review. Particular emphasis given to how the activities of quite different granule proteins are interdependent and how this contributes to the co-ordination and integration of the organelle's biological functions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526768     DOI: 10.1007/bf00265542

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  56 in total

1.  A METHOD FOR THE MICRODISSECTION OF INTACT PANCREATIC ISLETS OF MAMMALS.

Authors:  C HELLERSTROEM
Journal:  Acta Endocrinol (Copenh)       Date:  1964-01

2.  Primary structure of rat chromogranin A and distribution of its mRNA.

Authors:  A Iacangelo; H Okayama; L E Eiden
Journal:  FEBS Lett       Date:  1988-01-25       Impact factor: 4.124

3.  Physicochemical characteristics of insulin secretion granules.

Authors:  H G Coore; B Hellman; E Pihl; I B Täljedal
Journal:  Biochem J       Date:  1969-01       Impact factor: 3.857

4.  Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.

Authors:  K Tatemoto; S Efendić; V Mutt; G Makk; G J Feistner; J D Barchas
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

5.  Ca2+-dependent binding of cytosolic components to insulin-secretory granules results in Ca2+-dependent protein phosphorylation.

Authors:  K W Brocklehurst; J C Hutton
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

6.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

Authors:  G J Cooper; A C Willis; A Clark; R C Turner; R B Sim; K B Reid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Biosynthesis of betagranin in pancreatic beta-cells. Identification of a chromogranin A-like precursor and its parallel processing with proinsulin.

Authors:  J C Hutton; H W Davidson; K A Grimaldi; M Peshavaria
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

8.  Insulin secretion by a transplantable rat islet cell tumour.

Authors:  A M Sopwith; J C Hutton; S P Naber; W L Chick; C N Hales
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

9.  Biochemical and clinical implications of proinsulin conversion intermediates.

Authors:  B D Given; R M Cohen; S E Shoelson; B H Frank; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  5-Hydroxytryptamine transport in cells and secretory granules from a transplantable rat insulinoma.

Authors:  J C Hutton; M Peshavaria; N E Tooke
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

View more
  63 in total

1.  The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation.

Authors:  Fanling Meng; Andisheh Abedini; Annette Plesner; Chris T Middleton; Kathryn J Potter; Martin T Zanni; C Bruce Verchere; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2010-05-07       Impact factor: 5.469

2.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

Authors:  Ping Cao; Daniel P Raleigh
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

3.  Enrichment of beta cells from the human fetal pancreas by fluorescence activated cell sorting with a new monoclonal antibody.

Authors:  R R de Krijger; H J Aanstoot; G Kranenburg; A Verkerk; J F Jongkind; R van Strik; K J Lafferty; G J Bruining
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

4.  Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.

Authors:  Jeffrey R Brender; Samer Salamekh; Ayyalusamy Ramamoorthy
Journal:  Acc Chem Res       Date:  2011-09-25       Impact factor: 22.384

5.  Deamidation accelerates amyloid formation and alters amylin fiber structure.

Authors:  Emily B Dunkelberger; Lauren E Buchanan; Peter Marek; Ping Cao; Daniel P Raleigh; Martin T Zanni
Journal:  J Am Chem Soc       Date:  2012-07-17       Impact factor: 15.419

6.  Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.

Authors:  Fanling Meng; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2010-12-30       Impact factor: 5.469

7.  Expedited approaches to whole cell electron tomography and organelle mark-up in situ in high-pressure frozen pancreatic islets.

Authors:  Andrew B Noske; Adam J Costin; Garry P Morgan; Brad J Marsh
Journal:  J Struct Biol       Date:  2007-09-29       Impact factor: 2.867

8.  Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.

Authors:  A C Griffin; W Zhao; K W Wegmann; W F Hickley
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

9.  Role of aromatic interactions in amyloid formation by islet amyloid polypeptide.

Authors:  Ling-Hsien Tu; Daniel P Raleigh
Journal:  Biochemistry       Date:  2013-01-04       Impact factor: 3.162

10.  Monitoring of glucose-regulated single insulin secretory granule movement by selective photoactivation.

Authors:  S Baltrusch; S Lenzen
Journal:  Diabetologia       Date:  2008-04-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.